Novel Ratio Soluble Fms-like Tyrosine Kinase-1/Angiotensin-II (sFlt-1/ANG-II) in Pregnant Women Is Associated with Critical Illness in COVID-19

孕妇体内新型比例可溶性 Fms 样酪氨酸激酶-1/血管紧张素 II (sFlt-1/ANG-II) 与 COVID-19 危重疾病相关

阅读:8
作者:Salvador Espino-Y-Sosa, Raigam Jafet Martinez-Portilla, Johnatan Torres-Torres, Juan Mario Solis-Paredes, Guadalupe Estrada-Gutierrez, Jose Antonio Hernandez-Pacheco, Aurora Espejel-Nuñez, Paloma Mateu-Rogell, Angeles Juarez-Reyes, Francisco Eduardo Lopez-Ceh, Jose Rafael Villafan-Bernal, Lourdes Ro

Conclusion

sFlt-1/ANG-II ratio is a good predictor of adverse events such as pneumonia, ICU admission, intubation, sepsis, and death in pregnant women with COVID-19.

Methods

Prospective cohort study. Primary outcome was severe pneumonia. Secondary outcomes were ICU admission, intubation, sepsis, and death. Spearman's Rho test was used to analyze the correlation between sFlt-1 and ANG-II levels. The sFlt-1/ANG-II ratio was determined and the association with each adverse outcome was explored by logistic regression analysis and the prediction was assessed using receiver-operating-curve (ROC);

Results

Among 80 pregnant women with COVID-19, the sFlt-1/ANG-II ratio was associated with an increased probability of severe pneumonia (odds ratio [OR]: 1.31; p = 0.003), ICU admission (OR: 1.05; p = 0.007); intubation (OR: 1.09; p = 0.008); sepsis (OR: 1.04; p = 0.008); and death (OR: 1.04; p = 0.018);

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。